Helping our clients move healthcare and technology forward
Deal Announcement
SVB Securities Deal Announcement: Frazier Lifesciences Acquisition Corp. & NewAmsterdam Pharma
SVB Securities Served as PIPE Placement Agent to Frazier Lifesciences Acquisition Corp. (Nasdaq: FLAC) and Financial Advisor and Capital Markets Advisor to NewAmsterdam Pharma in Connection with its Completed Merger and $235 Million PIPE
Published November 28, 2022More Deal Announcement
View all Deal Announcement
Deal Announcement
SVB Securities Serves as Joint Bookrunner for Oculis Holding AG’s (Nasdaq: OCS) $40 Million Follow-On Offering
June 2023
Deal Announcement
SVB Securities Serves as Lead-Left Bookrunner for HOOKIPA Pharma’s (Nasdaq: HOOK) $50 Million Follow-On Offering
June 2023
Deal Announcement
SVB Securities Serves as Lead-Left Bookrunner for Belite Bio’s (Nasdaq: BLTE) $30 Million Follow-On Offering
May 2023
Featured Intelligence
View additional intelligenceSee also:
Capital Markets
Growth-oriented companies need an experienced partner with demonstrated capital-raising power
Learn MoreEquity Research
Investors benefit from our depth of coverage in healthcare and technology
Learn More